CSSi LifeSciences President Serves as Professional Mentor at NIH CAP FeedFoward

Glen Burnie, MD – Jim Sergi, President of CSSi LifeSciences™, recently participated as a professional mentor at the National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) FeedForward™ Session, organized by Larta Institute. 70 companies enrolled in the NIH CAP and 40 mentors, including representatives from GE, Siemens and John Hopkins University, participated in the highly anticipated two-day workshop in Washington, D.C.

As a mentor, Jim provided various medically and healthcare-driven entrepreneurs and startup companies with personalized feedback on the companies’ commercialization challenges, goals and program deliverables as presented in their 18-month “Commercialization Roadmap” and overall commercialization strategy. He also facilitated interactive discussions among participants and attending companies focusing on the pertinent topics of developing a successful business model, building a compelling value proposition and implementing an effective exit strategy.

“I am very grateful to have been given the opportunity to serve as a mentor at Larta Institute’s NIH CAP FeedForward™ Sessions this past week in D.C.,” said Jim Sergi, President of CSSi LifeSciences™. “It was a pleasure to be able to provide entrepreneurial firms with useful tools and resources necessary to meet their key development and commercialization goals. It is my hope that the participants I interacted directly with walked away with real world, pragmatic advice and solutions in which they can implement immediately to dramatically increase their business model and successfully transition their innovations into the marketplace.”

Jim is a recognized thought leader in the clinical research world and has played a major role in the commercial success and launch of over 400 drugs and biologics. In addition, he has established an effective and efficient model for helping companies and clients create a strategic pathway from discovery to commercialization that has resulted in a reduction of development time, costs and resources.

“We were so pleased Jim Sergi was available to bring his clinical research and commercialization expertise to our FeedForward™ sessions in Washington, D.C.,” said Judy Hsieh, Program Director, Larta Institute. “Getting the right people in the room for each company’s need is a Larta trademark.”

Larta Institute’s FeedForward™ Sessions are face-to-face, private workshops held as a part of the NIH CAP for medical and healthcare entrepreneurs to receive individualized and group input in a constructive manner, as well as in a candid and informal setting. These two-hour-long, roundtable sessions allow participating companies the opportunity to test run their business strategy on experienced and qualified industry leaders and experts. This is not only a transformative experience for entrepreneurs, but it also creates a monumental opportunity for industry leaders and experts to discover and interact directly with

emerging companies from across the country. The next FeedForward™ Session event will be held on Monday, March 21 in Irvine, California.

CSSi LifeSciences™ strives to provide innovative, fully integrated solutions and improved efficiencies that extends throughout the entire product lifecycle of a new drug or device, with the added benefit of improving quality health outcomes for patients. To learn more about CSSi LifeSciences™, please visit www.cssilifesciences.com or email us at lifesciences@cssienroll.com.

About CSSi LifeSciences™:

CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices and in-vitro diagnostics.

About Larta Institute:

Larta Institute, founded in Los Angeles in 1993, is an internationally-recognized technology accelerator that has helped more than 10,000 companies transform ideas into commercialized, socially-beneficial innovations in science and technology, particularly in agriculture and the life sciences. With a global network of entrepreneurs, mentors, investors, industry leaders, research institutions, government agencies and support organizations, Larta conducts commercialization accelerator programs throughout the U.S. and in more than 20 countries. For additional information about Larta Institute, visit the organization’s website at www.larta.org.

About the National Institutes of Health CAP:

The NIH Commercialization Acceleration Program (CAP), Larta Institute’s longest running commercialization program, provides tailored one-on-one advisors and business assistance to NIH’s top tier grantees in Phase II of the SBIR/STTR program. Through Larta’s trademark network-centric practice, our entrepreneurs receive the guidance and tools they need to transition their technologies to the marketplace. Designed to service each company’s unique needs, our NIH CAP has a notable track record of 26 acquisitions and over 680 deals signed.

About FeedForward™ Sessions:

FeedForward™ Sessions are closed-door, invitation-only workshop sessions for participating NIH CAP companies to pitch their 18-month strategic plans to industry and domain experts drawn from senior stakeholders, investors and other representatives in the medical and healthcare community. Larta designs each session with specific company needs in mind, for feedback on everything to do with their business and marketing model and practical advice on building and operating their companies.

###